Company Valuation: genOway

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 21.45 37.85 35.3 40.59 34.58 24.99
Change - 76.49% -6.76% 15% -14.82% -27.73%
Enterprise Value (EV) 1 29.49 43.07 39.45 43.56 35.2 31.7
Change - 46.05% -8.41% 10.42% -19.2% -9.93%
P/E - - - - - -
PBR - - - - - -
PEG - - - - - -
Capitalization / Revenue 1.32x 1.93x 1.67x 1.62x 1.34x 0.96x
EV / Revenue 1.81x 2.2x 1.87x 1.74x 1.36x 1.22x
EV / EBITDA 34.9x 99.8x 13.1x 7.49x 9.04x 7.16x
EV / EBIT -78.2x -54.6x 80.7x 27.8x 27x 24.9x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 - - - - - -
Distribution rate - - - - - -
Net sales 1 16.29 19.59 21.09 25.02 25.84 26.03
EBITDA 1 0.844 0.4318 3.006 5.815 3.894 4.428
EBIT 1 -0.3771 -0.7893 0.4886 1.565 1.304 1.274
Net income 1 -0.6873 -0.3226 0.7778 1.568 1.831 0.9278
Net Debt 1 8.045 5.22 4.156 2.973 0.623 6.718
Reference price 2 3.100 4.290 4.000 4.600 3.750 2.710
Nbr of stocks (in thousands) 6,919 8,824 8,824 8,824 9,220 9,220
Announcement Date 28/04/22 28/04/22 28/04/23 01/05/24 29/04/25 30/04/26
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 2.23Cr
18.77x6.69x13.41x1.58% 6.5TCr
35.3x6.27x18.74x0.92% 5.12TCr
27.56x7.53x23.83x0.05% 5.12TCr
34.01x3.32x14.33x-.--% 4.39TCr
48.9x5.59x30.73x-.--% 4.2TCr
-18.47x189.62x-19.51x-.--% 3.81TCr
28.97x8.21x21.25x0.37% 3.32TCr
29.19x6.17x16.01x-.--% 2.52TCr
30.74x5.69x19.09x-.--% 2.25TCr
Average 26.11x 26.57x 15.32x 0.32% 3.72TCr
Weighted average by Cap. 25.97x 25.01x 15.48x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - genOway

Historical PBR trend

Valuation ratios - PBR - genOway

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - genOway

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - genOway